BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Z, Xiao X, Saw PE, Wu W, Huang H, Chen J, Nie Y. Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment. Sci China Life Sci 2020;63:180-205. [PMID: 31883066 DOI: 10.1007/s11427-019-9665-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Shao F, Long Y, Ji H, Jiang D, Lei P, Lan X. Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring. Theranostics 2021;11:6800-17. [PMID: 34093854 DOI: 10.7150/thno.56989] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Marofi F, Motavalli R, Safonov VA, Thangavelu L, Yumashev AV, Alexander M, Shomali N, Chartrand MS, Pathak Y, Jarahian M, Izadi S, Hassanzadeh A, Shirafkan N, Tahmasebi S, Khiavi FM. CAR T cells in solid tumors: challenges and opportunities. Stem Cell Res Ther 2021;12:81. [PMID: 33494834 DOI: 10.1186/s13287-020-02128-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
3 Zhang ZZ, Wang T, Wang XF, Zhang YQ, Song SX, Ma CQ. Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies. Pharmacol Res 2021;175:106036. [PMID: 34920118 DOI: 10.1016/j.phrs.2021.106036] [Reference Citation Analysis]
4 Peng Q, Zhou Y, Oyang L, Wu N, Tang Y, Su M, Luo X, Wang Y, Sheng X, Ma J, Liao Q. Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics. Mol Ther 2021:S1525-0016(21)00581-5. [PMID: 34793975 DOI: 10.1016/j.ymthe.2021.11.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu F, Tian Y, Zhou L. Papillary meningioma of the central nervous system: a SEER database analysis. Neurosurg Rev 2021. [PMID: 33415520 DOI: 10.1007/s10143-020-01449-2] [Reference Citation Analysis]
6 Jin Y, Lyu Q. Basic research in childhood cancer: Progress and future directions in China. Cancer Lett 2020;495:156-64. [PMID: 32841714 DOI: 10.1016/j.canlet.2020.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang Y, Bao Y, Zhang S, Wang Z. Splicing dysregulation in cancer: from mechanistic understanding to a new class of therapeutic targets. Sci China Life Sci 2020;63:469-84. [PMID: 32086672 DOI: 10.1007/s11427-019-1605-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
8 Wang X, Ma C, Rodríguez Labrada R, Qin Z, Xu T, He Z, Wei Y. Recent advances in lentiviral vectors for gene therapy. Sci China Life Sci 2021;64:1842-57. [PMID: 34708326 DOI: 10.1007/s11427-021-1952-5] [Reference Citation Analysis]
9 Schaft N. The Landscape of CAR-T Cell Clinical Trials against Solid Tumors-A Comprehensive Overview. Cancers (Basel) 2020;12:E2567. [PMID: 32916883 DOI: 10.3390/cancers12092567] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
10 Feng L, Jing F, Qin X, Zhou L, Ning Y, Hou J, Kong W, Zhu Y. Cleavage Stimulation Factor Subunit 2: Function Across Cancers and Potential Target for Chemotherapeutic Drugs. Front Pharmacol 2022;13:852469. [DOI: 10.3389/fphar.2022.852469] [Reference Citation Analysis]
11 Miao L, Zhang Z, Ren Z, Tang F, Li Y. Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors. Front Immunol 2021;12:687822. [PMID: 34093592 DOI: 10.3389/fimmu.2021.687822] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Min J, Long C, Zhang L, Duan J, Fan H, Chu F, Li Z. c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549. Bioengineered 2022;13:9216-32. [PMID: 35378051 DOI: 10.1080/21655979.2022.2058149] [Reference Citation Analysis]
13 Qi X, Chen S, He H, Wen W, Wang H. The role and potential application of extracellular vesicles in liver cancer. Sci China Life Sci 2021;64:1281-94. [PMID: 33847910 DOI: 10.1007/s11427-020-1905-7] [Reference Citation Analysis]
14 Xie Q, Li F, Fang L, Liu W, Gu C. The Antitumor Efficacy of β-Elemene by Changing Tumor Inflammatory Environment and Tumor Microenvironment. Biomed Res Int 2020;2020:6892961. [PMID: 32149121 DOI: 10.1155/2020/6892961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Li H, Yang C, Cheng H, Huang S, Zheng Y. CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety. J Cancer 2021;12:1804-14. [PMID: 33613769 DOI: 10.7150/jca.50509] [Reference Citation Analysis]
16 Hernández-López A, Téllez-González MA, Mondragón-Terán P, Meneses-Acosta A. Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope. Front Pharmacol 2021;12:720692. [PMID: 34489708 DOI: 10.3389/fphar.2021.720692] [Reference Citation Analysis]
17 Ciccocioppo R, Comoli P, Astori G, Del Bufalo F, Prapa M, Dominici M, Locatelli F. Developing cell therapies as drug products. Br J Pharmacol 2021;178:262-79. [PMID: 33140850 DOI: 10.1111/bph.15305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]